Total Visits

Views
The ... 551

Total Visits Per Month

December 2024January 2025February 2025March 2025April 2025May 2025June 2025
The ... 9 3 5 12 18 12 28

File Visits

Views
The Cardiovascular Benefits of Empagliflozin, A Sodium Glucose Cotransporter Inhibitor Is NHE1 a Viable Target.pdf 227

Top country views

Views
United States 277
China 61
Singapore 29
Taiwan 16
Japan 14
Qatar 12
Australia 11
United Kingdom 10
Ireland 10
Argentina 9

Top cities views

Views
Colorado Springs 48
Ashburn 37
Sherman Oaks 17
Taipei 12
Oakland 11
Shanghai 11
Doha 10
Dublin 10
Giza 8
Beijing 7